Aspirin and Reye Syndrome

作者: Karsten Schr??r

DOI: 10.2165/00148581-200709030-00008

关键词:

摘要: Reye syndrome is an extremely rare but severe and often fatal disease. Death occurs in about 30–40% of cases from brainstem dysfunction. The disease typically preceded by a viral infection with intermediate disease-free interval 3–5 days. biochemical explanation for Reye-like symptoms generalized disturbance mitochondrial metabolism, eventually resulting metabolic failure the liver other tissues. etiology ‘classical’ unknown. Hypothetically, may result unusual response to preceding infection, which determined host genetic factors can be modified variety exogenous agents. Thus, several infections diseases might present clinically symptoms. Exogenous agents involve number toxins, drugs (including aspirin [acetylsalicylic acid]), chemicals. ‘rise fall’ incidence still poorly understood unexplained. With few exceptions, there were probably no new reported during last 10 years that could not explained inherited disorder metabolism or misdiagnosis. This reflect scientific progress better understanding cellular molecular dysfunctions as disease-determining factors. Alternatively, immune virulence virus have changed alteration its code. suggestion defined cause-effect relationship between intake children supported sufficient facts. Clearly, drug treatment without side effects. balanced view whether certain justified terms benefit/risk ratio always necessary. Aspirin exception.

参考文章(91)
PA Brogan, A Bose, David Burgner, D Shingadia, R Tulloh, C Michie, N Klein, R Booy, M Levin, MJ Dillon, Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research Archives of Disease in Childhood. ,vol. 86, pp. 286- 290 ,(2002) , 10.1136/ADC.86.4.286
BRIAN W. FORSYTH, Misdiagnosis of Reye's-like Illness Archives of Pediatrics & Adolescent Medicine. ,vol. 145, pp. 964- 966 ,(1991) , 10.1001/ARCHPEDI.1991.02160090014005
Audrey K. Brown, Senih Fikrig, Laurence Finberg, Aspirin and Reye syndrome The Journal of Pediatrics. ,vol. 102, pp. 157- 158 ,(1983) , 10.1016/S0022-3476(83)80319-9
H P van Bever, Aspirin, Reye syndrome, Kawasaki disease, and allergies; a reconsideration of the links Archives of Disease in Childhood. ,vol. 89, pp. 1178- 1178 ,(2004) , 10.1136/ADC.2004.055681
A Green, S M Hall, Investigation of metabolic disorders resembling Reye's syndrome. Archives of Disease in Childhood. ,vol. 67, pp. 1313- 1317 ,(1992) , 10.1136/ADC.67.10.1313
K. Morwood, D. Gillis, W. Smith, F. Kette, Aspirin-sensitive asthma Internal Medicine Journal. ,vol. 35, pp. 240- 246 ,(2005) , 10.1111/J.1445-5994.2004.00801.X
Yoshiko Tamaoki, Masahiko Kimura, Yuki Hasegawa, Misako Iga, Makoto Inoue, Seiji Yamaguchi, A survey of Japanese patients with mitochondrial fatty acid β-oxidation and related disorders as detected from 1985 to 2000 Brain and Development. ,vol. 24, pp. 675- 680 ,(2002) , 10.1016/S0387-7604(02)00074-8
J F T GLASGOW, Reye syndrome---insights on causation and prognosis Archives of Disease in Childhood. ,vol. 85, pp. 351- 353 ,(2001) , 10.1136/ADC.85.5.351
Z. Rahbeeni, F. M. Vaz, K. Al-Hussein, M. P. Bucknall, J. Ruiter, R. J. Wanders, M. S. Rashed, Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency Journal of Inherited Metabolic Disease. ,vol. 25, pp. 363- 369 ,(2002) , 10.1023/A:1020143632011